Literature DB >> 17785775

Bim and Bcl-2 mutually affect the expression of the other in T cells.

Trine N Jorgensen1, Amy McKee, Michael Wang, Ella Kushnir, Janice White, Yosef Refaeli, John W Kappler, Philippa Marrack.   

Abstract

The life and death of T cells is controlled to a large extent by the relative amounts of Bcl-2-related proteins they contain. The antiapoptotic protein Bcl-2 and the proapoptotic protein Bim are particularly important in this process with the amount of Bcl-2 per cell dropping by about one-half when T cells prepare to die. In this study we show that Bcl-2 and Bim each control the expression of the other. Absence of Bim leads to a drop in the amount of intracellular Bcl-2 protein, while having no effect on the amounts of mRNA for Bcl-2. Conversely, high amounts of Bcl-2 per cell allow high amounts of Bim, although in this case the effect involves increases in Bim mRNA. These mutual effects occur even if Bcl-2 is induced acutely. Thus these two proteins control the expression of the other, at either the protein or mRNA level.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17785775     DOI: 10.4049/jimmunol.179.6.3417

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Alternative splicing of Bim and Erk-mediated Bim(EL) phosphorylation are dispensable for hematopoietic homeostasis in vivo.

Authors:  C Clybouw; D Merino; T Nebl; F Masson; M Robati; L O'Reilly; A Hübner; R J Davis; A Strasser; P Bouillet
Journal:  Cell Death Differ       Date:  2012-01-13       Impact factor: 15.828

2.  Proapoptotic protein Bim is differentially required during thymic clonal deletion to ubiquitous versus tissue-restricted antigens.

Authors:  Alexander Y W Suen; Troy A Baldwin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-03       Impact factor: 11.205

3.  Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells.

Authors:  Delphine Mérino; Seong L Khaw; Stefan P Glaser; Daniel J Anderson; Lisa D Belmont; Chihunt Wong; Peng Yue; Mikara Robati; Belinda Phipson; Walter D Fairlie; Erinna F Lee; Kirsteen J Campbell; Cassandra J Vandenberg; Suzanne Cory; Andrew W Roberts; Mary J C Ludlam; David C S Huang; Philippe Bouillet
Journal:  Blood       Date:  2012-04-26       Impact factor: 22.113

4.  Examination of a second node of translational control in the unfolded protein response.

Authors:  Amanda M Preston; Linda M Hendershot
Journal:  J Cell Sci       Date:  2013-07-10       Impact factor: 5.285

Review 5.  Dying to protect: cell death and the control of T-cell homeostasis.

Authors:  Kun-Po Li; Sharmila Shanmuganad; Kaitlin Carroll; Jonathan D Katz; Michael B Jordan; David A Hildeman
Journal:  Immunol Rev       Date:  2017-05       Impact factor: 12.988

6.  Dynein light chain binding determines complex formation and posttranslational stability of the Bcl-2 family members Bmf and Bim.

Authors:  Prafull Kumar Singh; Aristomenis Roukounakis; Arnim Weber; Kushal Kumar Das; Benedicte Sohm; Andreas Villunger; Ana J Garcia-Saez; Georg Häcker
Journal:  Cell Death Differ       Date:  2019-06-12       Impact factor: 15.828

7.  Temporal Expression of Bim Limits the Development of Agonist-Selected Thymocytes and Skews Their TCRβ Repertoire.

Authors:  Kun-Po Li; Anke Fähnrich; Eron Roy; Carla M Cuda; H Leighton Grimes; Harris R Perlman; Kathrin Kalies; David A Hildeman
Journal:  J Immunol       Date:  2016-11-16       Impact factor: 5.422

Review 8.  Genetic control of programmed cell death during animal development.

Authors:  Barbara Conradt
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

9.  Elevated Mcl-1 inhibits thymocyte apoptosis and alters thymic selection.

Authors:  K J Campbell; D H D Gray; N Anstee; A Strasser; S Cory
Journal:  Cell Death Differ       Date:  2012-06-29       Impact factor: 15.828

10.  The BH3-only proteins Bim and Puma cooperate to impose deletional tolerance of organ-specific antigens.

Authors:  Daniel H D Gray; Fiona Kupresanin; Stuart P Berzins; Marco J Herold; Lorraine A O'Reilly; Philippe Bouillet; Andreas Strasser
Journal:  Immunity       Date:  2012-09-06       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.